Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Madrigal Pharmaceuticals Inc (NQ: MDGL )

109.04 USD -4.96 (-4.35%)
Official Closing Price Updated: 4:57 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Madrigal Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Sum Up The Parts: IHE Could Be Worth $208
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
FTXH's Holdings Could Mean 18% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SPRO CMPI ACIU
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags ADCT CYCC SBPH
From Benzinga
10 Biggest Price Target Changes For Friday
B of A Securities lowered the price target for Ollie's Bargain Outlet Holdings Inc (NASDAQ: OLLI) from $125 to $115. Ollie's ... 
Tags OLLI BKNG TBPH
From Benzinga
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ACAD ATRS KOD
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
This morning 118 companies reached new 52-week highs. Noteworthy Points: Alphabet (NASDAQ: GOOG) was the company with ... 
Tags XEL MOH DHR
From Benzinga
The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NVRO Offerings AZYO
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
During Wednesday's morning session, 143 companies made new 52-week highs. Points of Interest: The largest company ... 
Tags CP SSTK MTLS
From Benzinga
The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem's Q4, Codiak Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FATE ENZ Biotech
From Benzinga
The Daily Biotech Pulse: FDA Panel Review For Alkermes, Axovant Gets Rare Pediatric Disease Designation, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags EXAS CRDF SELB
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
During the morning session on Thursday, 186 stocks hit new 52-week highs. Interesting Highlights: Taiwan ... 
Tags PNR RUSHA Penny Stocks
From Benzinga
The Daily Biotech Pulse: Gilead, Lilly COVID-19 Treatment Supply Agreements, CareDx's Positive Preannouncement, Aziyo Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags PRLD GILD STOK
From Benzinga
Madrigal Pharmaceuticals Hits 80-Plus Relative Strength Rating Benchmark
Madrigal Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84. 
From Investor's Business Daily
Stocks To Watch: Madrigal Pharmaceuticals Sees Relative Strength Rating Jump To 80
Madrigal Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 68 to 80. 
From Investor's Business Daily
Analysts Anticipate 12% Gains Ahead For VB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Noteworthy Friday Option Activity: COF, MDGL, DAL
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Capital One Financial Corp (COF), where a total volume of 11,644 contracts has been... 
Tags Stocks
From Market News Video
Notable Monday Option Activity: MDGL, IRBT, HGV
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Madrigal Pharmaceuticals Inc (MDGL), where a total volume of 604 contracts has been... 
Tags Stocks
From Market News Video
Add Up The Parts: FTXH Could Be Worth $29
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Notable Wednesday Option Activity: RH, LORL, MDGL
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in RH (RH), where a total volume of 7,352 contracts has been traded thus far today, a... 
Tags Stocks
From Market News Video
2 Top Cancer Treatment Stocks To Watch In July
These hidden gems have the potential to deliver significant returns to their shareholders over the long run. 
Tags MOR ALXN MDGL
From Motley Fool
We Did The Math IHE Can Go To $187
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Notable Monday Option Activity: TWLO, MDGL, JEF
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Twilio Inc (TWLO), where a total volume of 13,392 contracts has been traded thus... 
Tags Stocks
From Market News Video
Better Buy: Intercept Pharmaceuticals vs. Madrigal Pharmaceuticals
These two companies are going after the same target, but which one should you bet on today? 
Tags MDGL Market News ICPT
From Motley Fool
Madrigal Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating
Madrigal Pharmaceuticals sees its Relative Strength Rating enter the 80-plus level. 
From Investor's Business Daily
Analysts Forecast 17% Gains Ahead For FTXH
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
3 Top Biotech Stocks to Buy in June
They have one big thing in common: great growth prospects. 
Tags BMY ICPT VRTX
From Motley Fool
The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Top Stories MRSN TARA
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 118 companies set new 52-week highs. Interesting Highlights: Facebook(NASDAQ: FB)was the largest firm ... 
Tags AVEO WERN IPHI
From Benzinga
Stocks That Hit 52-Week Highs On Friday
On Friday, 46 stocks hit new 52-week highs. Noteables: Shopify(NYSE: SHOP)was the largest firm by market cap to set ... 
Tags WIX Movers FATE
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.